Topical Delivery of Thymidine Dinucleotide to Induce p53 Generation in the Skin by Elastic Liposome

Transcription factor p53 has a powerful tumor suppressing function that is associated with many cancers. However, p53 of the molecular weight was higher make the limitation across to skin or cell membrane. Thymidine dinucleotide (pTT), an oligonucleotide, can activate the p53 transcription factor. pTT is a hydrophilic and negative charge oligonucleotide, which delivery in to cell membrane need an appropriate carrier. The aim of this study was to improve the bioavailability of the nucleotide fragment, thymidine dinucleotide (pTT), using elasic liposome carriers to deliver the drug into the skin. The study demonstrate that dioleoylphosphocholine (DOPC) incorporated with sodium cholate at molar ratio 1:1 can archived the particle size about 220 nm. This elastic liposome could penetration through skin from stratum corneum to whole epidermis by confocal laser scanning microscopy (CLSM). Moreover, we observed the the slight increase in generation of p53 by western blot.

Authors:

• Yi-Ping Fang
• Yi-Ting Wong

Keywords:

• Elastic liposome
• Tymidine dinucleotide
• p53
• Topical delivery

References:

[1] N. F. Box, T. Terzian, "The role of p53 in pigmentation, tanning and
melanoma," Pigment Cell Melanoma Res, vol. 21, pp. 525-533, Oct
2008.
[2] A. Sigal, V. Rotter, "Oncogenic mutations of the p53 tumor suppressor:
the demons of the guardian of the genome. Cancer Res," Cancer Res, vol.
60, pp. 6788-6793, Dec 2000.
[3] M. Oren, A. Damalas, T. Gottlieb, D. Michael, J. Taplick, J. F. Leal, R.
Maya, M. Moas, R. Seger, Y. Taya, A. Ben-Ze'Ev, "Regulation of p53:
intricate loops and delicate balances," Ann. N. Y. Acad. Sci., vol. 973. pp.
374-383, Nov 2002.
[4] P. M. Rodust, E. Stockfleth, C. Ulrich, M. Leverkus, J. Eberle,
"UV-induced squamous cell carcinoma - a role for antiapoptotic
signalling pathways," Br. J. Dermatol. vol. 161 Suppl 3, pp. S107-S115,
Nov 2009.
[5] C. L. Benjamin, S. E. Ullrich, M. L. Kripke, H. N. "p53 tumor suppressor
gene: a critical molecular target for UV induction and prevention of skin
cancer," Photochem. Photobiol., vol. 84. pp. 55-62, Jan-Feb 2008.
[6] D. A. Goukassian, M. S. Eller, M. Yaar, B. A. Gilchrest, "Thymidine
dinucleotide mimics the effect of solar simulated irradiation on p53 and
p53-regulated proteins," J. Invest. Dermatol., vol. 112. pp. 25-31, Jan
1999.
[7] E. Fattal, G. Barratt, "Nanotechnologies and controlled release systems
for the delivery of antisense oligonucleotides and small interfering RNA,"
Br. J. Pharmacol., vol. 157. pp. 179-194, May 2009.
[8] R. Parhi, S. Mondal, P. M. Kumar, "Novel Penetration Enhan cers for
Skin Applications: A Review," Curr. Drug. Deliv., Oct 2011. In press.
[9] D. Papakostas, F. Rancan, W. Sterry, U. Blume-Peytavi, A. Vogt,
"Nanoparticles in dermatology," Arch. Dermatol. Res., vol. 308. pp.
533-550, Oct 2011.
[10] L. Li, Y. Zhang, S. Han, Z. Qu, J. Zhao, Y. Chen, Z. Chen, J. Duan, Y.
Pan, X. Tang, "Penetration enhancement of lidocaine hydrochlorid by a
novel chitosan coated elastic liposome for transdermal drug delivery," J.
Biomed. Nanotechnol., vol. 7. pp. 704-713, Oct 2011.
[11] G. Cevc, G. Blume, "Lipid vesicles penetrate into intact skin owing to the
transdermal osmotic gradients and hydration force," Biochim. Biophys.
Acta, vol. 1104. pp. 226-232, Feb 1992.
[12] G. Cevc, G.Blume, "New, highly efficient formulation of diclofenac for
the topical, transdermal administration in ultradeform drug carriers,
Transfersomes," Biochim. Biophys. Acta, vol. 1514. pp. 191-205, Oct
2001.
[13] H. A. Benson, "Elastic liposomes for topical and transdermal drug
delivery," Curr Drug Deliv. vol. 6. pp. 217-226, Jul 2009.
[14] S. Duangjit, P. Opanasopit, T. Rojanarata, T. Ngawhirunpat, "Effect of
Edge Activator on Characteristic and in Vitro Skin Permeation of
Meloxicam Loaded in Elastic Liposomes," Adv. Mat. Res., vol. 194 pp.
537-540, Feb 2011.
[15] C. D. Pirvu, C. Hlevca, A. Ortan, R. Prisada, "Elastic vesicles as drugs
carriers through the skin," Farmacia, vol. 58 pp.128-135, 2010.
[16] D. A. Goukassian, M. S. Eller, M. Yaar, B. A. Gilchrest, "Thymidine
dinucleotide mimics the effect of solar simulated irradiation on p53 and
p53-regulated proteins," J. Invest. Dermatol., vol. 112 pp. 25-31, Jan
1999.
[17] P. L. Honeywell-Nguyen, J. A. Bouwstra, "The in vitro transport of
pergolide from surfactant-based elastic vesicles through human skin: a
suggested mechanism of action," J. Control. Release, vol. 86. pp.
145-156, Jan 2003.
[18] J. Mönkkönen, A. Urtti, "Lipid fusion in oligonucleotide and gene
delivery with cationic lipids," Adv. Drug Deliv. Rev., vol. 34 pp. 37-49,
Oct 1998.
[19] D. Hirsch-Lerner, M. Zhang, H. Eliyahu, M. E. Ferrari, C. J. Wheeler, Y.
Barenholz, "Effect of "helper lipid" on lipoplex electrostatics," Biochim.
Biophys. Acta, vol. 1714. pp. 71-84, Aug 2005.
[20] G. Cevc, "Transfersomes, liposomes and other lipid suspensions on the
skin: permeation enhancement, vesicle penetration, and transdermal drug
delivery," Crit. Rev. Ther. Drug Carrier Syst., vol. 13. pp. 257-388, 1996.
[21] G. Cevc, G. Blume, A. Schätzlein, D. Gebauer, A. Paul, "The skin: a
pathway for systemic treatment with patches and lipid-based agent
carriers," Adv. Drug Deliv. Rev, vol. 18. pp. 349-378, Feb 1996.
[22] G. Cevc, A. Schätzlein, H. Richardsen, U. Vierl "Overcoming
semi-permeable barriers, such as the skin, with ultradeformable mixed
lipid vesicles, Transfersomes, liposomes or mixed lipid micelles".
Langmuir, vol. 19. pp. 10753-10763, Aug 2003.
[23] Y. P. Fang, "Topical delivery of DNA oligonucleotide to induce p53
generation in the skin via thymidine dinucleotide (pTT)-encapsulated
liposomal carrier," Int. J. Nanomedicine, vol. 6. pp. 3373-3381, Dec
2011.